metastatic melanoma releases a high level of EVs that carry PD-L1 on their surface. Interferon-γ (IFN-γ) up-regulates PD-L1 on these vesicles, which suppresses the function of CD8 T cells and facilitates tumor growth. The gene discussed is CD8A; the disease is metastatic melanoma.